Hyperglycemia alters renal cell responsiveness to pressure in a model of malignant hypertension

Journal of Hypertension

Volumn 27, Issue 2, 2009, Pages 365-375

  Efrati, Shai ^a,b   Berman, Sylvia ^a   Tov, Yariv Siman ^a   Averbukh, Zhan ^a   Weissgarten, Joshua ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Apoptosis; Diabetes; Malignant hypertension; Oxidative stress; P53; Proliferation; Rennin angiotensin system

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN II; CAPTOPRIL; GLUCOSE; HYDROGEN PEROXIDE; LOSARTAN; PIFITHRIN ALPHA; PROTEIN P53; SARALASIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD PRESSURE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENDOTHELIUM CELL; HYDROSTATIC PRESSURE; HYPERGLYCEMIA; IN VITRO STUDY; KIDNEY CELL; KIDNEY ENDOTHELIUM; KIDNEY EPITHELIUM; KIDNEY INJURY; MALIGNANT HYPERTENSION; MESANGIUM; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; BIOSYNTHESIS; CELL LINE; CYTOLOGY; EPITHELIUM CELL; KIDNEY; MESANGIUM CELL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; CELL LINE; CELL PROLIFERATION; ENDOTHELIAL CELLS; EPITHELIAL CELLS; HYDROGEN PEROXIDE; HYDROSTATIC PRESSURE; HYPERGLYCEMIA; HYPERTENSION, MALIGNANT; KIDNEY; MESANGIAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 63849215308     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32831b46ab     Document Type: Article

References (40)

1. Tanaka Y, Atsumi Y, Matsuoka K, Onuma T, Tohjima T, Kawamori R. Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients. Diabetes Care 1998; 21:116-120.
2. Ibrahim H, Vora J. Diabetic nephropathy. Baillieris Best Pract Res Clin Endocrinol Metab 1999; 13:239-264.
3. Uemura S, Matsushita H, Li W, Glassford A, Asagami T, Lee K, et al. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res 2001; 88:1291-1298.
4. CatherwoodMA, Powell LA, Anderson P, McMaster D, Sharpe PC, Trimble ER. Glucose-induced oxidative stress in mesangial cells. Kidney Int 2002; 61:599-608.
5. Baynes J. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40:405-412.
6. Allen D, Harwood S, Vagarunam M, Raftery M, Yaqoob M. High glucoseinduced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J 2003; 17:908-910.
7. Hsieh T, Zhang S, Filep J, Tang S, Ingelfinger J, Chan J. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 2002; 143:2975-2985.
8. Christensen P, Hansen H, Parving H. Impaired autoregulation of GFR in hypertensive noninsulin-dependent diabetic patients. Kidney Int 1997; 52:1369-1374.
9. Parving H, Kastrup H, Smidt U, Andersen A, Feldt-Rasmussen B, Christiansen J. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 1984; 27:547-552.
10. Arima S, Sadayoshi I. The mechanisms underlying altered vascular resistance of glomerular afferent and efferent arterioles in diabetic nephropathy. Nephr Dial Transpl 2003; 18:1966-1969.
11. Singhal PC, Sharma P, Loona R, Gibbons N, Franki N, Klotman PE. Enhanced proliferation, apoptosis and matrix accumulation by mesangial cells derived from HIV transgenic mice. J Investig Med 1998; 46:297-302.
12. Singhal PC, Gibbons N, Franki N, Reddy K,Mattana J, Wagner J. Simulated glomerular hypertension promotes mesangial cell apoptosis and expression of Cathepsin-B and SGP-2. J Investig Med 1998; 46:42-50.
13. Samikkanu T, Thomas J, Bhat J, Wittman Y, Thkkumara T. Acute effect of high glucose on long-term cell growth: a role of transient glucose increase in proximal tubule cell injury. Am J Physiol Renal Physiol 2006; 291:162-175.
14. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, Haverty TP. High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubules. Am J Physiol 1990; 259:704-714.
15. Wolf G, Neilson EG. Angiotensin II induces cellular hypertrophy in cultured murine tubular cells. Am J Physiol 1990; 259:768-777.
16. Wolf G, Neilson EG, Goldfarb S, Ziyadeh FN. The influence of glucose concentration on angiotensin II-induced hypertrophy of proximal tubular cells in culture. Biochem Biophys Res Commun 1991; 179:902-909.
17. Wolf G, Killen PD, Neilson EG. Intracellular signaling of transcription and secretion of type IV collagen after angiotensin II-induced cellular hypertrophy in cultured proximal tubular cells. Cell Regul 1991; 2:219-227.
18. Wolf G, Mueller E, Stahl RAK, Ziyedah FN. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-ß. J Clin Invest 1993; 92:1366-1372.
19. Bakris GL. Angiotensin-converting enzyme inhibitors and the progression of diabetic nephropathy. Ann Intern Med 1993; 118:643-644.
20. Rodrigues-Lopes AM, Flores O, Arevalo MA, Lopes-Novoa JM. Glomerular cell proliferation and apoptosis in uninephrectomized spontaneously hypertensive rats. Kidney Int 1998; 68:36-40.
21. Efrati S, Berman S, Goldfinger N, Erez N, Averbukh Z, Golik A, et al. Enhanced angiotensin II production by renal mesangium is responsible for apoptosis/proliferation of endothelial and epithelial cells in a model of malignant hypertension. J Hypertens 2007; 25:1041-1052.
22. Burns K. Angiotensin II and its receptors in the diabetic kidney. Am J Kidney Dis 2000; 36:449-467.
23. Miyake-Ogawa C, Miyazaki M, Abe K, Harada T, Ozono Y, Sakai H, et al. Tissue-specific expression of renin-angiotensin components in IgA nephropathy. Am J Nephrol 2005; 25:1-12.
24. Nguen G, Burckle C, Sraer J. Renin/prorenin-receptor biochemistry and functional significance. Curr Hypertens Rep 2004; 6:129-132.
25. Ignjacev-Lazich I, Kintsurashvili E, Johns C, Vitseva O, Duka A, Shenouda S, et al. Angiotensin-converting enzyme regulates bradykinin receptor gene expression. Am J Physiol Heart Circ Physiol 2005; 289: H1814-H1820.
26. Oppong S, Hooper N. Characterization of a secretase activity which releases angiotensin converting enzyme from the membrane. Biochem J 1993; 292:597-603.
27. Filipeanu C, Henning R, Neleman S, de Zeew D. Intracellular angiotensin II: from myth to reality. J Renin Angiotensin Aldosterone Syst 2001; 2:219-226.
28. Filipeanu C, Brailou E, Kok J, Henning R, de Zeeuw D, Neleman S. Intracellular Angiotensin II elicits Ca increases in A&R vascular smooth muscle cells. Eur J Pharmacol 2001; 420:9-18.
29. Lely A, Luik P, Navis G. Angiotensin I-converting enzyme: a pathogenic role in diabetic damage? Curr Diabetes Rev 2007; 3:41-52.
30. Fiordalizo F, Leri A, Ceselli D, Limana F, Safai B, Nadal-Ginard B, et al. Hyperglycemia alters p53 and p53-regulated genes leading to myocyte cell death. Diabetes 2001; 50:2363-2375.
31. Kane C, Greenhalgh D. Expression and localizationof p53 and bcl-2 in healing wounds in diabetic and nondiabetic mice. Wound repair Regen 2000; 8:45-58.
32. Menini S, Iacobini C, Oddi G, Ricci C, Simonelli P, Fallucca S, et al. Increased glomerular cell (podocyte) apoptosis in rats with streptozotocininduced diabetes mellitus: role in the development of diabetic glomerular disease. Diabetologia 2007; 50:2591-2599.
33. Pekar O, Molotski N, Savion S, Fein A, Toder V, Torchinsky A. p53 regulates cyclophosphamide teratogenesis by controlling caspases 3, 8, 9 activation and NF-kappaB DNA binding. Reproduction 2007; 134:379-388.
34. Brezniceanu M, Liu F, Wei C, Chenier I, Godin N, Zhang S, et al. Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells. Diabetes 2008; 57:451-459.
35. Vairaktaris E, Kalokerinos G, Goutzanis L, Spyridonidou S, Vassiliou S, Derka S, et al. Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesis. Anticancer Res 2007; 27:1465-1473.
36. Park SH, Choi HJ, Lee JH, Woo CH, Kim JH, Han HJ. High glucose inhibits renal proximal tubule cell proliferation and involves PKC, oxidative stress, and TGF-b1. Kidney Int 2001; 59:1695-1705.
37. Park CW, Kim JH, Lee WJ, Kim YS, Ahn HJ, Shin YS, et al. High glucoseinduced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kB dependent. Diabetologia 2000; 43:1544-1553.
38. Leri A, Claudio P, Li Q, Wang X, Cheng W, Kadjstura J, Anversa P. Stretchmediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl02-to-Bax protein ratio in the cell. J Clin Invest 1998; 101:1326-1342.
39. Leri A, Fiordalizo F, Setoguchi M, Limana F, Bishopric N, Kadjstura J, et al. Inhibition of p53 function prevents renin-angiotensin system activation and stretch-mediated myocyte apoptosis. Am J Pathol 2000; 157:843-857.
40. Leri A, Liu Y, Claudio P, Kadjstura J, Wang X, Wang S, et al. Insulin-like growth factor-1 induces Mdm2 and downregulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis. Am J Pathol 1999; 154:567-580.